Scorpius leverages real-time PCR, also known as quantitative PCR (qPCR), to support the preclinical and clinical phases of therapeutic development. Our instrumentation enables simultaneous measurement of multiple DNA amplification reactions in a single reaction vessel, making it possible to process a large number of samples simultaneously. In addition, this enables reaction volumes at nanoliter levels, substantially saving reagents and samples needed to perform the testing.
Our scientific team offers a wealth of expertise in the development, optimization, and validation of complex molecular assays using conventional and qPCR.
